11-28113366-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001113528.2(METTL15):āc.32A>Gā(p.Tyr11Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000352 in 1,589,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001113528.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
METTL15 | NM_001113528.2 | c.32A>G | p.Tyr11Cys | missense_variant | 3/7 | ENST00000407364.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
METTL15 | ENST00000407364.8 | c.32A>G | p.Tyr11Cys | missense_variant | 3/7 | 5 | NM_001113528.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000383 AC: 9AN: 235224Hom.: 0 AF XY: 0.0000626 AC XY: 8AN XY: 127770
GnomAD4 exome AF: 0.0000195 AC: 28AN: 1437814Hom.: 0 Cov.: 28 AF XY: 0.0000168 AC XY: 12AN XY: 713242
GnomAD4 genome AF: 0.000184 AC: 28AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.32A>G (p.Y11C) alteration is located in exon 3 (coding exon 1) of the METTL15 gene. This alteration results from a A to G substitution at nucleotide position 32, causing the tyrosine (Y) at amino acid position 11 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at